Project Grant R43DA064222
Award Date 6/1/26
Completion Date 5/31/27
Dollars Obligated $400K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse awarded $651,468 to the University of Texas at Austin on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop, evaluate, and disseminate StatWiseAI, an artificial intelligence-powered educational tool designed to enhance methodological rigor in the analysis of complex, large-scale datasets. The project, responding to RFA-DA-25-039: Education Activities for Responsible Analyses of...
- Federal Grant Award Summary Biomotivate LLC received a $613,744 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a non-invasive digital therapeutic tool for individuals with opioid use disorders (OUDs). Awarded on August 1, 2025, with completion targeted for July 31, 2027, the project delivers a precision medicine...
- Federal Grant Award Summary Princeton University received a $164,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 15, 2025, with completion targeted for July 31, 2027. The award supports development of a Chemical Artificial Intelligence (AI) and Data Science Platform designed to identify and discover novel psychoactive substances (NPS). The project will deliver three primary products: (1) a...
- Federal Grant Award Summary Taesun, LLC received a $610,738 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop an integrated fentanyl testing device. The award, effective August 1, 2025, through August 31, 2026, supports the creation of a streamlined testing solution that consolidates multiple operational steps—including sample crushing, measuring, and assaying—into a single, user-friendly unit. This...
- Federal Grant Award Summary Carina Medical LLC received a $304,215 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025 and concluding July 31, 2026. The awardee is developing and validating a novel software platform designed to enable decentralized clinical trials (DCTs) for substance use disorder (SUD) research, with integration of large language models (LLMs). This platform addresses significant...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $248,201 in Project Grant funding to University of Colorado-Denver (effective April 15, 2026, through March 31, 2028) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct independent validation research on cannabis detection technologies. The two-year study will rigorously assess the performance, reliability, and predictive validity of two breath sampling devices and two ocular (pupil dynamics)...
- Federal Grant Award Summary Rescue Biomedical, LLC received a $799,430 Phase I Small Business Innovation Research (SBIR) Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), with an award date of August 1, 2025 and completion date of July 31, 2026. The award supports the development and commercialization of the Automatic Detection Device (AD2), a user-centric wearable detection module designed to identify...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of California, Irvine $235,500 under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and deploy an artificial intelligence-based chatbot designed to enhance engagement in mobile peer-to-peer support groups for smoking cessation. The project, initiated June 1, 2026, with completion targeted for April 30, 2029, involves refining an intelligent chatbot built on a state-of-the-art large...
- Federal Grant Award Summary Pillsmart Inc. received a $399,993 Phase I Small Business Innovation Research (SBIR) project grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded June 1, 2026, with completion targeted for May 31, 2027. The company is developing LEVL, a clinical decision support (CDS) system designed to identify early relapse risk among adolescents with substance use disorders. The platform integrates...
- Federal Grant Award Summary The University of California, San Diego received a $437,250 Project Grant (R21 Developmental/Exploratory Grant) from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective July 15, 2025, with completion targeted for June 30, 2027. This research initiative will produce the first comprehensive longitudinal dataset characterizing parental use of digital location tracking (DLT) technology—such as Apple's Find My,...